Doximity, Inc. 8-K

What Happened
Doximity, Inc. (DOCS) filed an 8‑K on May 13, 2026 attaching a press release with its financial results for the fiscal quarter and year ended March 31, 2026 (Exhibit 99.1). The company also announced executive appointments: Matthew Sonefeldt was named Chief Financial Officer effective May 13, 2026 (to formally become the company’s Principal Financial Officer on June 8, 2026), and Steven L. Zatz, M.D. was appointed President effective May 13, 2026. Siddharth Sitaram will continue as interim Principal Financial Officer through June 7, 2026.

Key Details

• Press release dated May 13, 2026 attached as Exhibit 99.1 reports Doximity’s quarterly and fiscal year results for period ended March 31, 2026 (see the release for financial line items).
• Matthew Sonefeldt (age 46) — 25 years of investor relations, strategy and operations experience (most recently Head of Investor Relations at DocuSign): base salary $400,000; annual target bonus $400,000; initial RSU grant valued at $9,000,000 vesting quarterly over 3 years; additional performance‑based RSUs valued at $3,000,000 vesting annually over 3 years. He signed Doximity’s standard indemnification agreement.
• Steven L. Zatz, M.D. (age 69) — longtime digital health executive (prior roles include CEO/President at WebMD and HealthCentral): base salary $400,000; annual target bonus $500,000 paid quarterly; initial RSU grant valued at $1,000,000 vesting quarterly over 1 year; additional performance RSUs valued at $1,700,000 vesting in one year. He signed Doximity’s standard indemnification agreement.
• Interim Principal Financial Officer Siddharth Sitaram remains in that role through June 7, 2026; Sonefeldt becomes Principal Financial Officer effective June 8, 2026.

Why It Matters
The 8‑K combines Doximity’s public reporting of fiscal Q4/FY2026 results with management changes that affect financial leadership and company operations. A permanent CFO and a seasoned digital‑health president may influence investor communications, financial reporting cadence, and strategic execution. The disclosed compensation and sizable equity grants highlight management incentives and potential future dilution; investors should review the attached press release for the detailed financial results and monitor upcoming filings (e.g., 10‑Q/10‑K) for more context.